Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vaginal spermicides, chromosomal abnormalities and limb reduction defects.

J F Cordero, P M Layde

    Family Planning Perspectives
    |January 1, 1983
    PubMed
    Summary

    Vaginal spermicide use during pregnancy does not increase the risk of birth defects like Down syndrome or limb reduction defects. This study found no statistically significant link between spermicide exposure and these developmental abnormalities.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Impacts of trace mineral source and ancillary drench on steer performance during a 60-day backgrounding phase.

    Animal : an international journal of animal bioscience·2024
    Same author

    The role of epidemiology in informing United States childhood immunization policy and practice.

    Annals of epidemiology·2020
    Same author

    Patient risk factors for medical injury: a case-control study.

    BMJ quality & safety·2011
    Same author

    Medical injuries among hospitalized children.

    Quality & safety in health care·2006
    Same author

    Incidence of sports and recreation related injuries resulting in hospitalization in Wisconsin in 2000.

    Injury prevention : journal of the International Society for Child and Adolescent Injury Prevention·2005
    Same author

    All STDs are not created equal: an analysis of the differential effects of sexual behaviour changes on different STDs.

    International journal of STD & AIDS·2003

    Area of Science:

    • Reproductive Health
    • Teratology
    • Obstetrics

    Background:

    • Vaginal spermicides are used by a significant number of women of childbearing age.
    • Previous reports suggested a potential link between spermicide use and adverse birth outcomes, including chromosomal abnormalities and limb defects.

    Purpose of the Study:

    • To investigate the teratogenic potential of vaginal spermicides.
    • To evaluate the association between spermicide use around conception and the risk of specific birth defects in offspring.

    Main Methods:

    • A case-control study utilizing data from the Metropolitan Atlanta Congenital Defects Program (MACDP).
    • Compared spermicide use around conception in mothers of infants with chromosomal abnormalities and limb reduction defects versus mothers of infants with other birth defects.
    Keywords:
    Chromosome AbnormalitiesCongenital AbnormalitiesContraceptionContraceptive AgentsContraceptive UsageDiseasesFamily PlanningGeorgiaNeonatal Diseases And AbnormalitiesPregnancyPregnancy OutcomesProbabilityReproductionResearch MethodologyResearch ReportSpermicidal Contraceptive AgentsStatistical StudiesStudiesUnited States

    Related Experiment Videos

    Main Results:

    • The relative risk for Down syndrome in infants exposed to spermicides was 1.2.
    • The relative risk for other chromosomal abnormalities was 1.2.
    • The relative risk for limb reduction defects following first-trimester exposure was 1.0.
    • No statistically significant increased risk was observed for any of the studied birth defects.

    Conclusions:

    • The findings do not support the hypothesis that vaginal spermicides are teratogenic.
    • Current evidence suggests spermicide use around conception is not associated with an increased risk of Down syndrome, other chromosomal abnormalities, or limb reduction defects.